• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童癌症幸存者中颈动脉超声筛查的患病率:来自儿童癌症幸存者研究的报告。

Prevalence of carotid ultrasound screening in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.

作者信息

Bryce Yolanda, Whitton Jillian A, Stratton Kayla L, Leisenring Wendy M, Chow Eric J, Armstrong Gregory, Weil Brent, Dieffenbach Bryan, Howell Rebecca M, Oeffinger Kevin C, Nathan Paul C, Tonorezos Emily S

机构信息

Memorial Sloan Kettering, New York, New York, USA.

Fred Hutchinson Cancer Center, Seattle, Washington, USA.

出版信息

Cancer. 2025 Jan 1;131(1):e35591. doi: 10.1002/cncr.35591. Epub 2024 Oct 10.

DOI:10.1002/cncr.35591
PMID:39388304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11695176/
Abstract

INTRODUCTION

Many childhood cancer survivors are at risk for cardiovascular disease and stroke. The North American Children's Oncology Group long-term follow-up guidelines recommend carotid ultrasound in cancer survivors 10 years after neck radiation therapy (RT) ≥40 Gy. The use of carotid ultrasound in this population has not been described.

METHODS

Survivors of childhood cancer diagnosed 1970-1999 (N = 8693) and siblings (N = 1989) enrolled in the Childhood Cancer Survivor Study were asked if they had ever had a carotid ultrasound. Prevalence of carotid ultrasound was evaluated. Prevalence ratios (PR) and 95% confidence intervals (CIs) were evaluated in multivariate Poisson regression models.

RESULTS

Among participants with no reported cardiovascular condition, prevalence of carotid ultrasound among survivors with RT ≥40 Gy to the neck (N = 172) was 29.7% (95% CI, 22.5-36.8), significantly higher than those with <40 Gy (prevalence 10.7%; 95% CI, 9.9%-11.4%). Siblings without a cardiovascular condition (N = 1621) had the lowest prevalence of carotid ultrasound (4.7%; 95% CI, 3.6%-5.7%). In a multivariable models among survivors with no reported cardiovascular condition and RT ≥40 Gy to the neck, those who were over age 50 (vs. 18-49) at follow-up (PR = 1.82; 95% CI, 1.09-3.05), with a history of seeing a cancer specialist in the last 2 years (PR = 2.58; 95% CI, 1.53-4.33), or having a colonoscopy (PR = 2.02; 95% CI, 1.17-3.48) or echocardiogram (PR = 6.42; 95% CI, 1.54-26.85) were more likely to have had a carotid ultrasound.

CONCLUSION

Many survivors do not undergo carotid ultrasound despite meeting existing guidelines. Health care delivery features such as having seen a cancer specialist or having other testing are relevant.

摘要

引言

许多儿童癌症幸存者面临心血管疾病和中风的风险。北美儿童肿瘤学组的长期随访指南建议,接受颈部放射治疗(RT)≥40 Gy的癌症幸存者在放疗10年后进行颈动脉超声检查。目前尚未对该人群中颈动脉超声的使用情况进行描述。

方法

纳入儿童癌症幸存者研究的1970 - 1999年确诊的儿童癌症幸存者(N = 8693)和兄弟姐妹(N = 1989)被问及是否曾进行过颈动脉超声检查。评估颈动脉超声检查的患病率。在多变量泊松回归模型中评估患病率比(PR)和95%置信区间(CI)。

结果

在未报告有心血管疾病的参与者中,颈部接受≥40 Gy放疗的幸存者(N = 172)中颈动脉超声检查的患病率为29.7%(95% CI,22.5 - 36.8),显著高于接受<40 Gy放疗的幸存者(患病率10.7%;95% CI,9.9% - 11.4%)。无心血管疾病的兄弟姐妹(N = 1621)颈动脉超声检查的患病率最低(4.7%;95% CI,3.6% - 5.7%)。在未报告有心血管疾病且颈部接受≥40 Gy放疗的幸存者的多变量模型中,随访时年龄超过50岁(vs. 18 - 49岁)者(PR = 1.82;95% CI,1.09 - 3.05)、过去2年内有看癌症专科医生史者(PR = 2.58;95% CI,1.53 - 4.33)、进行过结肠镜检查者(PR = 2.02;95% CI,1.17 - 3.48)或超声心动图检查者(PR = 6.42;95% CI,1.54 - 26.85)更有可能进行过颈动脉超声检查。

结论

尽管符合现有指南,但许多幸存者并未接受颈动脉超声检查。诸如看过癌症专科医生或进行过其他检查等医疗服务提供特征与之相关。

相似文献

1
Prevalence of carotid ultrasound screening in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.儿童癌症幸存者中颈动脉超声筛查的患病率:来自儿童癌症幸存者研究的报告。
Cancer. 2025 Jan 1;131(1):e35591. doi: 10.1002/cncr.35591. Epub 2024 Oct 10.
2
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.
3
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Long-term hormone therapy for perimenopausal and postmenopausal women.围绝经期和绝经后女性的长期激素治疗
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.
6
Platinum-induced hearing loss after treatment for childhood cancer.儿童癌症治疗后铂诱导的听力损失。
Cochrane Database Syst Rev. 2016 Aug 3;2016(8):CD010181. doi: 10.1002/14651858.CD010181.pub2.
7
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
8
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
9
Incentives for preventing smoking in children and adolescents.预防儿童和青少年吸烟的激励措施。
Cochrane Database Syst Rev. 2017 Jun 6;6(6):CD008645. doi: 10.1002/14651858.CD008645.pub3.
10
Effectiveness and tolerability of pharmacologic and combined interventions for reducing injection pain during routine childhood immunizations: systematic review and meta-analyses.药物及联合干预措施在减轻儿童常规免疫接种时注射疼痛方面的有效性和耐受性:系统评价与荟萃分析
Clin Ther. 2009;31 Suppl 2:S104-51. doi: 10.1016/j.clinthera.2009.08.001.

引用本文的文献

1
Approaches to Reduce Toxicity in Pediatric Brain Tumors.降低小儿脑肿瘤毒性的方法。
Curr Oncol. 2025 May 15;32(5):281. doi: 10.3390/curroncol32050281.

本文引用的文献

1
Association analysis of self-reported outcomes with a validated subset.与验证子集的自我报告结果的关联分析。
Stat Med. 2024 Feb 20;43(4):642-655. doi: 10.1002/sim.9976. Epub 2023 Dec 13.
2
Interventions to address disparities and barriers to pediatric cancer survivorship care: a scoping review.解决儿科癌症生存者照护差距和障碍的干预措施:范围综述。
J Cancer Surviv. 2022 Jun;16(3):667-676. doi: 10.1007/s11764-021-01060-4. Epub 2021 Jun 16.
3
Adherence to Surveillance for Second Malignant Neoplasms and Cardiac Dysfunction in Childhood Cancer Survivors: A Childhood Cancer Survivor Study.儿童癌症幸存者中第二恶性肿瘤和心功能障碍监测的依从性:一项儿童癌症幸存者研究。
J Clin Oncol. 2020 May 20;38(15):1711-1722. doi: 10.1200/JCO.19.01825. Epub 2020 Mar 6.
4
A primer on model selection using the Akaike Information Criterion.关于使用赤池信息准则进行模型选择的入门知识。
Infect Dis Model. 2020 Jan 7;5:111-128. doi: 10.1016/j.idm.2019.12.010. eCollection 2020.
5
Barriers and facilitators of risk-based health care for adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.基于风险的成年癌症患儿幸存者医疗保健的障碍和促进因素:来自儿童癌症幸存者研究的报告。
Cancer. 2020 Feb 1;126(3):619-627. doi: 10.1002/cncr.32568. Epub 2019 Oct 18.
6
Increased Risk of All Cardiovascular Disease Subtypes Among Childhood Cancer Survivors: Population-Based Matched Cohort Study.儿童癌症幸存者患所有心血管疾病亚型的风险增加:基于人群的匹配队列研究。
Circulation. 2019 Sep 17;140(12):1041-1043. doi: 10.1161/CIRCULATIONAHA.119.041403. Epub 2019 Aug 26.
7
Promoting Breast Cancer Surveillance: The EMPOWER Study, a Randomized Clinical Trial in the Childhood Cancer Survivor Study.推动乳腺癌监测:EMPOWER 研究,儿童癌症幸存者研究中的一项随机临床试验。
J Clin Oncol. 2019 Aug 20;37(24):2131-2140. doi: 10.1200/JCO.19.00547. Epub 2019 Jul 1.
8
Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention.儿童癌症幸存者的心血管疾病:流行病学、病理生理学和预防的见解。
J Clin Oncol. 2018 Jul 20;36(21):2135-2144. doi: 10.1200/JCO.2017.76.3920. Epub 2018 Jun 6.
9
Blood Pressure Status in Adult Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study.儿童癌症幸存者的血压状况:来自圣裘德终身队列研究的报告。
Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1705-1713. doi: 10.1158/1055-9965.EPI-17-0510. Epub 2017 Nov 22.
10
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).2016年欧洲心脏病学会(ESC)实践指南委员会主持制定的关于癌症治疗与心血管毒性的立场文件:欧洲心脏病学会(ESC)癌症治疗与心血管毒性特别工作组。
Eur Heart J. 2016 Sep 21;37(36):2768-2801. doi: 10.1093/eurheartj/ehw211. Epub 2016 Aug 26.